Evidence map›Paper›PMID 26666739›Full record

ArticleBMC biotechnology2015

Development and characterization of a eukaryotic expression system for human type II procollagen.

Andrew Wieczorek, Naghmeh Rezaei, Clara K Chan, Chuan Xu, Preety Panwar, Dieter Brömme, Erika F Merschrod S, Nancy R Forde

Open access · goldAbstract read
In one paragraph

Article in BMC biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Collagen- and hyaluronic acid-based hydrogels and their biomedical applications.Materials science & engineering. R, Reports : a review journal · 2021
    Article
  8. Engineered Collagen Matrices.Bioengineering (Basel, Switzerland) · 2020
    Review
  9. Review
  10. Tension in fibrils suppresses their enzymatic degradation - A molecular mechanism for 'use it or lose it'.Matrix biology : journal of the International Society for Matrix Biology · 2020
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Andrew WieczorekDepartment of Physics, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.
Naghmeh RezaeiDepartment of Physics, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.
Clara K ChanDepartment of Physics, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.
Chuan XuDepartment of Chemistry, Memorial University, St. John's, NL, A1B 3X7, Canada.
Preety PanwarFaculty of Dentistry, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Dieter BrömmeFaculty of Dentistry, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Erika F Merschrod SDepartment of Chemistry, Memorial University, St. John's, NL, A1B 3X7, Canada.
Nancy R FordeDepartment of Physics, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada. nforde@sfu.ca.
Simon Fraser University · CAMemorial University of Newfoundland · CAUniversity of British Columbia · CA

Funding

Canadian Institutes of Health Research MOP-8994Medical Research Council MOP-125866
6 · The paper itself

Abstract

backgroundTriple helical collagens are the most abundant structural protein in vertebrates and are widely used as biomaterials for a variety of applications including drug delivery and cellular and tissue engineering. In these applications, the mechanics of this hierarchically structured protein play a key role, as does its chemical composition. To facilitate investigation into how gene mutations of collagen lead to disease as well as the rational development of tunable mechanical and chemical properties of this full-length protein, production of recombinant expressed protein is required.

resultsHere, we present a human type II procollagen expression system that produces full-length procollagen utilizing a previously characterized human fibrosarcoma cell line for production. The system exploits a non-covalently linked fluorescence readout for gene expression to facilitate screening of cell lines. Biochemical and biophysical characterization of the secreted, purified protein are used to demonstrate the proper formation and function of the protein. Assays to demonstrate fidelity include proteolytic digestion, mass spectrometric sequence and posttranslational composition analysis, circular dichroism spectroscopy, single-molecule stretching with optical tweezers, atomic-force microscopy imaging of fibril assembly, and transmission electron microscopy imaging of self-assembled fibrils.

conclusionsUsing a mammalian expression system, we produced full-length recombinant human type II procollagen. The integrity of the collagen preparation was verified by various structural and degradation assays. This system provides a platform from which to explore new directions in collagen manipulation.

Indexed as

Cathepsin KCell Line, TumorCircular DichroismClone CellsCollagen Type IIEukaryotaExtracellular MatrixFibrosarcomaHumansMicroscopy, Atomic ForceOptical TweezersProcollagenRecombinant ProteinsTransfectionCathepsin KCollagen Type IIProcollagenRecombinant Proteins

Identifiers

PMID26666739
PMCPMC4678704
OpenAlexW2221173327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.